^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Hodgkin Lymphoma |
| Regimen: | EPIC (cisplatin + etoposide IV + ifosfamide + ) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pediatric Hodgkin Lymphoma...Relapsed/Refractory Disease...Subsequent Therapy Options...EPIC (etoposide, prednisolone, ifosfamide, cisplatin)
